Susceptibility of Gram-negative bacteria to isepamicin: a systematic review

International Transfer of NDM-1-ProducingKlebsiella pneumoniaefrom Iraq to France

(2011) Laurent Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutant APH(2'')-IIa Enzymes with Increased Activity against Amikacin and Isepamicin

(2010) M. Toth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Epidemiology, Sequence Types, and Plasmid Analyses of KPC-Producing Klebsiella pneumoniae Strains in Israel

(2010) A. Leavitt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence ofKlebsiella pneumoniaeCoproducing KPC-2 and 16S rRNA Methylase ArmA in Poland

(2010) Katarzyna Zacharczuk et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials

(2010) George Samonis et al.   Future Microbiology

Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates

(2010) D. M. Livermore et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial Susceptibility Patterns of KPC-Producing or CTX-M-Producing Enterobacteriaceae

(2010) Mariana Castanheira et al.   Microbial Drug Resistance

Resistance Plasmid Families in Enterobacteriaceae

(2009) A. Carattoli   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes

(2009) Maria Souli et al.   CLINICAL INFECTIOUS DISEASES

Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation

(2009) A. Michalopoulos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence of 16S rRNA methylase genes in Klebsiella pneumoniae isolates from a Chinese teaching hospital: coexistence of rmtB and armA genes in the same isolate

(2009) Fangyou Yu et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Pandrug Resistance (PDR), Extensive Drug Resistance (XDR), and Multidrug Resistance (MDR) among Gram‐Negative Bacilli: Need for International Harmonization in Terminology

(2008) Matthew E. Falagas et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin

(2008) M. E. Falagas et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives

(2008) Matthew E Falagas et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Do we still need the aminoglycosides?

(2008) Emanuele Durante-Mangoni et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis

(2008) Kazuyoshi Shigehara et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY